Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Ma, Dennis ^a   Tremblay, Phillip ^a   Mahngar, Kevinjeet ^a   Collins, Jonathan ^b   Hudlicky, Tomas ^b   Pandey, Siyaram ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEOXYPANCRATISTATIN; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CURCUMIN; ENDONUCLEASE G; JC TH ACETATE 4; PANCRATISTATIN; REACTIVE OXYGEN METABOLITE; TAMOXIFEN; UNCLASSIFIED DRUG; 7-DEOXYPANCRATISTATIN; AMARYLLIDACEAE ALKALOID; ISOQUINOLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ISOLATION; FETUS CELL; FIBROBLAST; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOSARCOMA CELL; SPICE; CHEMISTRY; DOSE RESPONSE; METABOLISM; MITOCHONDRION; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE;

AMARYLLIDACEAE ALKALOIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; ISOQUINOLINES; MITOCHONDRIA; OSTEOSARCOMA;

EID: 83755206343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028780     Document Type: Article

References (70)

1. Aggarwal B, Kumar A, Bharti A, (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23 (1A): 363-398.
2. Singh S, (2007) From exotic spice to modern drug? Cell 130: 765-768.
3. Kuttan R, Bhanumathy P, Nirmala K, George M, (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29 (2): 197-202.
4. Walters DK, Muff R, Langsam B, Born W, Fuchs B, (2008) Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs 26 (4): 289-97 Epub 2007 Dec 11.
5. Arndt CA, Crist WM, (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342-352.
6. Marina N, Gebhardt M, Teot L, Gorlick R, (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422-441.
7. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, et al. (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20 (3): 776-90.
8. Baum ES, Gaynon P, Greenberg L, Krivit W, Hammond D, (1981) Phase II trail cisplatin in refractory childhood cancer: children's cancer study group report. Cancer Treat Rep 65: 815-822.
9. Smith MA, Ungerleider RS, Horowitz ME, Simon R, (1991) Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst 83: 1460-1470.
10. Meistrich ML, Chawla SP, da Cunha MF, Johnson SL, Plager C, et al. (1989) Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 63: 2115-2123.
11. Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer WH, et al. (1991) Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol 9: 600-5.
12. Kekre N, Griffin C, McNulty J, Pandey S, (2005) Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 56 (1): 29-38.
13. McLachlan A, Kekre N, McNulty J, Pandey S, (2005) Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 10 (3): 619-630.
14. Siedlakowski P, McLachlan-Burgess A, Griffin C, Tirumalai SS, McNulty J, et al. (2007) Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria. Cancer Biol Ther 7 (3): 376-384.
15. Chatterjee SJ, McNulty J, Pandey S, (2010) Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound. Melanoma Res Epub 2010 Mar 17.
16. Griffin C, Hamm C, McNulty J, Pandey S, (2010) Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells. Cancer Cell Int 10: 6.
17. Griffin C, Karnik A, McNulty J, Pandey S, (2011a) Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts. Molecular Cancer Therapeutics 10 (1): 57-68.
18. Griffin C, McNulty J, Pandey S, (2011b) Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells. Int J Oncol 38 (6): 1549-56.
19. Collins J, Rinner U, Moser M, Hudlicky T, Ghiviriga I, et al. (2010) Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine. J Org Chem 75 (9): 3069-84.
20. Borst P, Rottenberg S, (2004) Cancer cell death by programmed necrosis? Drug Resist Updat 7 (6): 321-4 [Epub 2005 Jan 11].
21. Liu JJ, Lin M, Yu JY, Liu B, Bao JK, (2010) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 300 (2): 105-14 [Epub 2010 Oct 30].
22. Reed JC, (2000) Mechanisms of Apoptosis. American Journal of Pathology 157 (5): 1415-1430.
23. Earnshaw WC, (1999) Apoptosis. A cellular poison cupboard. Nature 397 (6718): 387-389.
24. Michael OH, (2000) The biochemistry of apoptosis. Nature 407: 770-777.
25. Kroemer G, Mariño G, Levine B, (2010) Autophagy and the integrated stress response. Mol Cell 40 (2): 280-93.
26. Levine B, (2007) Cell biology: autophagy and cancer. Nature 446 (7137): 745-7.
27. Gozuacik D, Kimchi A, (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (16): 2891-906.
28. Patel BB, Majumdar AP, (2009) Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutr Cancer 61 (6): 842-6.
29. Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G, (2010) Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 62 (8): 1137-41.
30. Zhang G, Gurtu V, Kain SR, Yan G, (1997) Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 23 (3): 525-31.
31. Madesh M, Hajnóczky G, (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155 (6): 1003-15 [Epub 2001 Dec 10].
32. Simon HU, Haj-Yehia A, Levi-Schaffer F, (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (5): 415-8.
33. Batandier C, Leverve X, Fontaine E, (2004) Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem 279 (17): 17197-204 [Epub 2004 Feb 11].
34. Cochemé HM, Murphy MP, (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283 (4): 1786-98 [Epub 2007 Nov 26].
35. Degterev A, Boyce M, Yuan J, (2003) A decade of caspases. Oncogene 22 (53): 8543-67.
36. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B, (2010) Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6 (3): 322-9 [Epub 2010 Apr 26].
37. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19 (21): 5720-8.
38. Pollack M, Leeuwenburgh C, (2001) Apoptosis and Aging: Role of the Mitochondrial. Journal of Gerontology 11: 475-482.
39. Gregory CD, Devitt A, (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113 (1): 1-14.
40. Singal PK, Iliskovic N, (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 1998 Sep 24;339 (13): 900-5.
41. Ta LE, Espeset L, Podratz J, Windebank AJ, (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27(6): 992-1002. Epub 2006 May 9.
42. Flombaum CD, Meyers PA, (1999) High-dose leucovorin as sole therapy for methotrexate toxicity. J Clin Oncol 17 (5): 1589-94.
43. Gurjal A, An T, Valdivieso M, Kalemkerian GP, (1999) Etoposide-induced pulmonary toxicity. Lung Cancer 26 (2): 109-12.
44. Loebstein R, Koren G, (1998) Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics 101 (6): E8.
45. Zilfou JT, Lowe SW, (2009) Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1 (5): a001883.
46. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ, (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A 84 (21): 7716-9.
47. Navaraj A, Mori T, El-Deiry WS, (2005) Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers. Cancer Biol Ther 4 (12): 1409-1414.
48. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (6718): 441-6.
49. Li LY, Luo X, Wang X, (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412 (6842): 95-9.
50. Gogvadze V, Orrenius S, Zhivotovsky B, (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18 (4): 165-73.
51. Chen G, Wang F, Trachootham D, Huang P, (2010) Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 10 (6): 614-25.
52. Warburg O, (1956) On the origin of cancer cells. Science 123 (3191): 309-14.
53. Gambhir SS, (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2 (9): 683-93.
54. Gatenby RA, Gillies RJ, (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4 (11): 891-9.
55. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB, (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7 (1): 11-20.
56. Gogvadze V, Zhivotovsky B, Orrenius S, (2010) The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 31 (1): 60-74.
57. Plas DR, Thompson CB, (2002) Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 13 (2): 75-8.
58. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, et al. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (1): 37-51.
59. Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (5930): 1029-33.
60. Pastorino JG, Shulga N, Hoek JB, (2002) Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277 (9): 7610-8.
61. Green DR, Kroemer G, (2004) The pathophysiology of mitochondrial cell death. Science 305 (5684): 626-9.
62. Casellas P, Galiegue S, Basile AS, (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40 (6): 475-86.
63. Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, et al. (2011) Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 133 (1): 86-91 [Epub 2010 Sep 16].
64. Chatterjee SJ, Ovadje P, Mousa M, Hamm C, Pandey S, (2011) The efficacy of dandelion root extract in inducing apoptosis in drug-resistant human melanoma cells. Evid Based Complement Alternat Med 2011: 129045 Epub 2010 Dec 30.
65. Ravindran J, Prasad S, Aggarwal BB, (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11 (3): 495-510.
66. Kurien BT, Singh A, Matsumoto H, Scofield RH, (2007) Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 5 (4): 567-76.
67. Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S, (2008) Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and-independent apoptosis in L929 cells. Free Radic Biol Med 45 (10): 1403-12 Epub 2008 Aug 16.
68. Rashmi R, Kumar S, Karunagaran D, (2005) Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26 (4): 713-23 Epub 2005 Jan 20.
69. Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S, (2007) Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem 102 (3): 580-92.
70. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, et al. (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72 (1): 29-39 Epub 2007 Mar 29.